![MKT-077-FJ-776-DataSheet-生命科學試劑-MedChemExpress_第1頁](http://file4.renrendoc.com/view/4ee0c5c6354366190fb6b34fb07dd91c/4ee0c5c6354366190fb6b34fb07dd91c1.gif)
![MKT-077-FJ-776-DataSheet-生命科學試劑-MedChemExpress_第2頁](http://file4.renrendoc.com/view/4ee0c5c6354366190fb6b34fb07dd91c/4ee0c5c6354366190fb6b34fb07dd91c2.gif)
![MKT-077-FJ-776-DataSheet-生命科學試劑-MedChemExpress_第3頁](http://file4.renrendoc.com/view/4ee0c5c6354366190fb6b34fb07dd91c/4ee0c5c6354366190fb6b34fb07dd91c3.gif)
![MKT-077-FJ-776-DataSheet-生命科學試劑-MedChemExpress_第4頁](http://file4.renrendoc.com/view/4ee0c5c6354366190fb6b34fb07dd91c/4ee0c5c6354366190fb6b34fb07dd91c4.gif)
下載本文檔
版權說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權,請進行舉報或認領
文檔簡介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEMKT-077Cat. No.: HY-15096CAS No.: 147366-41-4Synonyms: FJ-776分式: CHClNOS分量: 432作靶點: HSP作通路: Cell Cycle/DNA Damage; Metabolic Enzyme/Protease儲存式: Powder -20C 3 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實驗 DMSO : 41.67 mg/mL
2、 (96.46 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 2.3148 mL 11.5741 mL 23.1481 mL5 mM 0.4630 mL 2.3148 mL 4.6296 mL10 mM 0.2315 mL 1.1574 mL 2.3148 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。體內(nèi)實驗 請根據(jù)您的實驗動物和給藥式選擇適當?shù)娜芙獍福渲魄罢埾扰渲瞥吻宓膬湟?,再依次添加助溶?為保證實驗結果的可靠性,體內(nèi)實驗的作液,建議您現(xiàn)現(xiàn)配,
3、當天使;澄清的儲備液可以根據(jù)儲存條件,適當保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.08 mg/mL (4.81 mM); Clear solution2. 請依序添加每種溶劑: 10% DMSO 90% corn oilSolubility: 2.08 mg/mL (4.81 mM); Clear solution1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEBIOLOGICAL AC
4、TIVITY物活性 MKT-077種花菁染料,也 種熱休克蛋 70 (Hsp70) 抑制劑,且具有顯著的抗腫瘤活性。IC50 & Target HSP70體外研究 MKT-077 is a rhodacyanine dye and also a heat shock protein 70 (Hsp70) inhibitor which exhibits significantantitumor activity. MKT-077 treatment (0.1 to 10 M dose ranges) for 48 hours can effectively decrease TTcell vi
5、ability. MKT-077 treatment results in accumulation of cells in the G0/G1 phase in a dose-dependentmanner, and also increases sub-G0/G1 phase population in TT cell culture in a dose-dependent manner.MKT-077 also downregulates cellular levels of the proliferation marker, Ki67, and the S-phase transcri
6、ptionfactor, E2F-1, in TT and MZ-CRC-1 cells. Moreover, flow cytometry using different doses of MKT-077reveales that TT cells can uptake and retain MKT-077 at significantly higher levels than MZ-CRC-1 cells 1.MKT-077 has EC50 values of 1.40.2 and 2.20.2 M against MDA-MB-231 and MCF7 breast cancer ce
7、lls,respectivelyl 2.體內(nèi)研究 Systemic administration of MKT-077 significantly delays the growth of TT xenografts in mice throughout thetreatment. At the end of MKT-077 treatment, it is found that tumor weights are about two-times less in MKT-077-treated group than in control group. MKT-077 treatment als
8、o results in weight loss and general toxicity inanimals 1. Results show that the succinate-induced, ADP-stimulated respiratory rate in mitochondriaisolated from the liver of rats treated with a bolus i.v. injection of 15 mg MKT-077 1kg body weight each dayfor 5 days is significantly lower than that
9、of untreated controls 3.PROTOCOLCell Assay 1 Cells are incubated with 1 M MKT-077 and 100 nM Mitotracker Green FM in culture medium for 30 minutesat 37C in the dark, washed with PBS, switched into phenol-red free medium before visualizing fluorescenceunder a microscope. Pictures are acquired and pro
10、cessed with software. For flow cytometric measurement,MKT-077-treated cells are resuspended in 0.1% bovine serum albumin/PBS and analyzed by flow cytometry.Data from 20,000 cells are analyzed using FCS Express software 1.MCE has not independently confirmed the accuracy of these methods. They are for
11、 reference only.Animal The 1107 TT cells in 200 L Hanks balanced salt solution are inoculated subcutaneously into the rearAdministration 1 flanks of 6-week-old female athymic nude (nu/nu) mice. Once palpable, tumors are measured using calipersat intervals indicated in the text. When tumor volume rea
12、ches 100 mm3, mice are sorted into groups of 8 toachieve equal distribution of tumor size in all treatment groups. Group 1 receives only the vehicle (1:9mixture of DMSO/saline) and group 2 receives MKT-077 (10 mg/kg body weight/dose). A 200 L of ethersolution is administered by intraperitoneal injec
13、tion every 2 days (total 10 doses). At the end of theexperiments, animals are euthanized by CO2 asphyxiation 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE1. Starenki D, et al. Selective Mit
14、ochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and InVivo. Endocrinol Metab (Seoul). 2015 Dec;30(4):593-603.2. Li X, et al. Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents. ACS Med Chem Lett.2013 Nov 14;4(11).3. Weisberg EL, et al. In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function. Cancer Res.1996 Fe
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 公司在職員工培訓服務合同書
- 礦山企業(yè)安全生產(chǎn)許可證頒發(fā)與管理作業(yè)指導書
- 反擔保合同協(xié)議1
- 游戲美術設計制作實戰(zhàn)手冊作業(yè)指導書
- 針紡織品銷售購銷合同
- 小學二年級數(shù)學上冊口算
- 2025年紹興a2貨運從業(yè)資格證模擬考試題
- 2024-2025學年高中語文專題一小說家想說些什么第1課在酒樓上學案蘇教版選修短篇小說蚜
- 七年級班級工作總結
- 四年級第一學期德育工作計劃
- 普外腹腔鏡手術護理常規(guī)
- 2024年全國職業(yè)院校技能大賽(礦井災害應急救援賽項)考試題庫(含答案)
- 《預制高強混凝土風電塔筒生產(chǎn)技術規(guī)程》文本附編制說明
- 監(jiān)控系統(tǒng)調(diào)試檢驗批質(zhì)量驗收記錄(新表)
- 元宵節(jié)猜燈謎PPT
- 錦州市主要環(huán)境問題論文
- 黃桃種植示范基地可行性研究報告
- 東風4型內(nèi)燃機車檢修規(guī)程
- 藥品經(jīng)營企業(yè)GSP計算機系統(tǒng)培訓PPT課件
- 建筑工程冬期施工規(guī)程JGJT1042011
- 畢業(yè)論文市場營銷畢業(yè)論文
評論
0/150
提交評論